Literature DB >> 20962548

Removal of ventricular shunts.

Wajd N Al-Holou1, Jayson A Sack, Hugh J L Garton, Karin M Muraszko, Cormac O Maher.   

Abstract

BACKGROUND: Although most patients with an implanted ventriculoperitoneal shunt device will require cerebrospinal fluid diversion over the course of their lifetime, there appears to be a small number of patients that are shunt independent and may benefit from shunt removal.
METHODS: We retrospectively analyzed 661 patients with hydrocephalus treated over a 10-year period at a single institution. In 10 patients, a systematic shunt weaning protocol was attempted before removal of the cerebrospinal fluid shunt.
RESULTS: Ten patients underwent an attempt at shunt removal. Seven of these patients were successfully weaned and 3 were not. The indications to attempt shunt removal for the 7 patients that were successfully weaned were recurrent complications and infections requiring multiple shunt externalizations and revisions in 4 patients, asymptomatic shunt disconnection in 2 patients, and symptomatic overdrainage in 1 patient. None of the patients that were successfully weaned had a history of shunt failure resulting in ventriculomegaly. Two of the 3 patients who failed shunt weaning attempts had a history of shunt failure that resulted in ventriculomegaly.
CONCLUSION: A small number of patients with shunted hydrocephalus may benefit from removal of their shunt.
Copyright © 2010 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2010        PMID: 20962548     DOI: 10.1159/000321921

Source DB:  PubMed          Journal:  Pediatr Neurosurg        ISSN: 1016-2291            Impact factor:   1.162


  2 in total

1.  Ventriculoperitoneal shunt malfunction caused by fractures and disconnections over 10 years of follow-up.

Authors:  Fatih Serhat Erol; Sait Ozturk; Bekir Akgun; Metin Kaplan
Journal:  Childs Nerv Syst       Date:  2017-01-17       Impact factor: 1.475

2.  Ventriculoperitoneal shunt management in children undergoing liver transplantation.

Authors:  Michael J Cools; Elizabeth Haley Vance; Christopher M Bonfield
Journal:  Childs Nerv Syst       Date:  2021-11-10       Impact factor: 1.532

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.